Join Now

Category Archives: BioUtah News

Hatch Warns of Dangers to the Generic Drug Market

By Natalie Themm | Published November 18, 2021

Statement from Senator Orrin G. Hatch: Drug Pricing Provisions in Infrastructure Bill Could Undermine Hatch-Waxman

| Leave a comment

NuView Life Sciences Creates Subsidiary for Latin American Market

By Natalie Themm | Published November 17, 2021

Introducing a New Approach to Diagnose and Treat Cancer.  NuView Life Sciences, Inc established NuView LATAM in Mexico City. 

| Tagged | Leave a comment

FDA clears the nView s1 imaging system with integrated navigation

By Natalie Themm | Published November 17, 2021

nView announces the 510(k) clearance of the nView s1 with navigation option by the FDA along with AI-enabled image analysis and 3D stitching

| Tagged | Leave a comment

Co-Diagnostics Reports Continued Strength in Third Quarter 2021 Financial Results

By Natalie Themm | Published November 17, 2021

Solid quarterly results highlighted by record revenue of $30.1 million, pre-tax income of $13.6 million and fully diluted EPS of $0.38

| Tagged , | Leave a comment

State Legislature Passes Statute regulating mandatory vaccination policies in the workplace.

By Natalie Themm | Published November 10, 2021

The Utah legislature convened in special session this week regarding the issuance of an OSHA Emergency Temporary Standard (ETS) requiring the vaccination of all employees of companies with more than 100 employees.

| Leave a comment

AdvaMed Statement on Administration’s COVID-19 Testing Policy for Employers

By Natalie Themm | Published November 10, 2021

AdvaMed released a statement from AdvaMedDx Executive Director Susan Van Meter on the testing policy regulation recently proposed by the Occupational Safety and Health Administration (OSHA) for employers with 100 or more employees under the Administration’s vaccine mandate.

| Tagged | Leave a comment

PolarityTE Reports Third Quarter Financial Results and Provides Business Update

By Natalie Themm | Published November 10, 2021

PolarityTE, Inc. recently provided a business update and reported financial results for the three and nine-month periods ended September 30, 2021.

| Tagged | Leave a comment

Renalytix Convenes Expert Panel at VA Healthcare Summit

By Natalie Themm | Published November 10, 2021

Leading clinicians discuss enabling long-term kidney health in Veterans with type 2 diabetes and early-stage chronic kidney disease

| Tagged | Leave a comment

St. Joseph’s Health and Renalytix Partner to Advance Value-Based Kidney Health in New York

By Natalie Themm | Published November 9, 2021

Partnership expands doctor and patient access to advanced prognosis and coordinated care management of early-stage diabetic kidney disease

| Tagged | Leave a comment

Sumitomo Dainippon Pharma Oncology Announces First Patient Dosed in Phase 1 Study of DSP-0390 in Patients with Recurrent High-Grade Glioma 

By Denise Bell | Published November 4, 2021

Sumitomo Dainippon Pharma Oncology (SDP Oncology), which has research facilities in Lehi, Utah, recently announced that the first patient has been dosed in a Phase 1 study evaluating its investigational agent DSP-0390, an emopamil-binding protein (EBP) inhibitor, for the treatment of patients with recurrent high-grade glioma. “Dosing the first patient in this study represents another […]

Also posted in Industry News, Utah's Life Sciences Companies | | Leave a comment

Co-Diagnostics, Inc. Logix Smart™ COVID-19 2-Gene Test Approved for Use in the United Kingdom

By Natalie Themm | Published November 4, 2021

Company’s validated test available in the UK following implementation of UKHSA CTDA Regulations

| Tagged , | Leave a comment

New report shows more than 260 medicines in development to fight neurodegenerative diseases

By Natalie Themm | Published November 3, 2021

PhRMA released a new report detailing the more than 260 medicines in development for 29 neurodegenerative diseases

| Tagged | Leave a comment

A Special Thanks To Our Legacy and Platinum Elite Members